Skip to main content
SpringerLink
Log in

Rituximab

Crohn's-disease, ulcerative colitis and indeterminate inflammatory bowel disease: 7 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Kristjansson VB, et al. Increased risk of inflammatory bowel disease among patients treated with rituximab in Iceland from 2001 to 2018. Scandinavian Journal of Gastroenterology 56: 46-52, No. 1, Jan 2021. Available from: URL: http://doi.org/10.1080/00365521.2020.1854847

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rituximab. Reactions Weekly 1844, 394 (2021). https://doi.org/10.1007/s40278-021-91841-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-91841-2

Search

Navigation